F092

CAS No. 2250261-59-5

F092( —— )

Catalog No. M36304 CAS No. 2250261-59-5

F092 is a potent inhibitor of hematopoietic prostaglandin D synthetase (H-PGDS), which can be used to study allergic inflammation and vascular-related diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 85 Get Quote
5MG 187 Get Quote
10MG 312 Get Quote
25MG 508 Get Quote
50MG 724 Get Quote
100MG 963 Get Quote
500MG 1917 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    F092
  • Note
    Research use only, not for human use.
  • Brief Description
    F092 is a potent inhibitor of hematopoietic prostaglandin D synthetase (H-PGDS), which can be used to study allergic inflammation and vascular-related diseases.
  • Description
    F092 is a potent inhibitor of hematopoietic prostaglandin D synthetase (H-PGDS), which can be used to study allergic inflammation and vascular-related diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    PGE synthase
  • Recptor
    PGE Synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2250261-59-5
  • Formula Weight
    359.38
  • Molecular Formula
    C20H17N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=CC=C(C=C1)N2C(=O)CCC2)C=3C=NC(=NC3)C4=NC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Crisdesalazine

    Crisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE(2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro.

  • mPGES1-IN-17d

    mPGES1-IN-17d is a potent, selective mPGES-1 inhibitor with enzyme IC50 of 8 nM, A549 cell IC50 of 16.24 nM.

  • Limaprost

    Limaprost is an analog of PGE1 with structural modifications intended to give it a prolonged half-life and greater potency.It is a potent and orally active vasodilator.?Limaprost increases blood flow and inhibits platelet aggregation.?Limaprost can be used for pain relief, has antianginal effects, and has potential for ?ischaemic symptoms treatment.